These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18299792)

  • 1. Reversal of the expression pattern of Aldolase C mRNA in Purkinje cells and Ube 1x mRNA in Golgi cells by a dopamine D1 receptor agonist injections in the methamphetamine sensitized-rat cerebellum.
    Hamamura M; Hirata N; Sawada K; Shuto T; Shimazoe T; Terada Y; Fukumaki Y
    J Neural Transm (Vienna); 2008 Jul; 115(7):959-71. PubMed ID: 18299792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential decreases in c-fos and aldolase C mRNA expression in the rat cerebellum after repeated administration of methamphetamine.
    Hamamura M; Ozawa H; Kimuro Y; Okouchi J; Higasa K; Iwaki A; Fukumaki Y
    Brain Res Mol Brain Res; 1999 Jan; 64(1):119-31. PubMed ID: 9889345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective changes in the shapes of parasagittal bands of Aldoc (Zebrin) mRNA in the rat vermis of the cerebellum after repeated methamphetamine injections.
    Hamamura M; Watanabe S; Fukumaki Y
    Cerebellum; 2004; 3(4):236-47. PubMed ID: 15686102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T; Seeman P; Kuroiwa M; Nishi A
    Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
    Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
    Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat.
    Gresch PJ; Walker PD
    Brain Res Mol Brain Res; 1999 Jun; 70(1):125-34. PubMed ID: 10381550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cloning of zebrin II reveals its identity with aldolase C.
    Ahn AH; Dziennis S; Hawkes R; Herrup K
    Development; 1994 Aug; 120(8):2081-90. PubMed ID: 7925012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated administration of methamphetamine blocked cholecystokinin-octapeptide injection-induced c-fos mRNA expression without change in capsaicin-induced junD mRNA expression in rat cerebellum.
    Hamamura M; Ozawa H; Ozaki M; Shimazoe T; Terada Y; Fukumaki Y
    J Neural Transm (Vienna); 2010 Sep; 117(9):1041-53. PubMed ID: 20680358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in neuronal immunofluorescence in the C- versus N-terminal domains of hnRNP H following D1 dopamine receptor activation.
    Ruan QT; Yazdani N; Beierle JA; Hixson KM; Hokenson KE; Apicco DJ; Luttik KP; Zheng K; Maziuk BF; Ash PEA; Szumlinski KK; Russek SJ; Wolozin B; Bryant CD
    Neurosci Lett; 2018 Sep; 684():109-114. PubMed ID: 30003938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens.
    Yamada H; Kuroki T; Nakahara T; Hashimoto K; Tsutsumi T; Hirano M; Maeda H
    Brain Res; 2007 Feb; 1131(1):88-96. PubMed ID: 17169339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of c-fos and zif/268 gene expression in rat striatal neurons, following stimulation of D1-like dopamine receptors, involves protein kinase A and protein kinase C.
    Simpson CS; Morris BJ
    Neuroscience; 1995 Sep; 68(1):97-106. PubMed ID: 7477939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain.
    Alonso R; Gnanadicom H; Fréchin N; Fournier M; Le Fur G; Soubrié P
    Eur J Neurosci; 1999 Mar; 11(3):967-74. PubMed ID: 10103090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour.
    Ferré S; Rimondini R; Popoli P; Reggio R; Pèzzola A; Hansson AC; Andersson A; Fuxe K
    Eur J Neurosci; 1999 Nov; 11(11):3884-92. PubMed ID: 10583477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons.
    Frau L; Morelli M; Simola N
    Exp Neurol; 2013 Sep; 247():663-72. PubMed ID: 23499830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat.
    Lanza K; Chemakin K; Lefkowitz S; Saito C; Chambers N; Bishop C
    Psychopharmacology (Berl); 2020 Jan; 237(1):155-165. PubMed ID: 31435690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.